| 000 | 01300 a2200397 4500 | ||
|---|---|---|---|
| 005 | 20250518025602.0 | ||
| 264 | 0 | _c20190311 | |
| 008 | 201903s 0 0 eng d | ||
| 022 | _a1791-7530 | ||
| 024 | 7 |
_a10.21873/anticanres.13249 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLiu, Yen-Ting | |
| 245 | 0 | 0 |
_aPrognostic Factors and Treatment Outcomes of Adult Patients With Rhabdomyosarcoma After Multimodality Treatment. _h[electronic resource] |
| 260 |
_bAnticancer research _cMar 2019 |
||
| 300 |
_a1355-1364 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xtherapeutic use |
| 650 | 0 | 4 | _aCombined Modality Therapy |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRhabdomyosarcoma _xpathology |
| 650 | 0 | 4 | _aSurvival Analysis |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 | _aYoung Adult |
| 700 | 1 | _aWang, Chun-Wei | |
| 700 | 1 | _aHong, Ruey-Long | |
| 700 | 1 | _aKuo, Sung-Hsin | |
| 773 | 0 |
_tAnticancer research _gvol. 39 _gno. 3 _gp. 1355-1364 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.21873/anticanres.13249 _zAvailable from publisher's website |
| 999 |
_c29449042 _d29449042 |
||